Blomberg Bjørn, Manji Karim P, Urassa Willy K, Tamim Bushir S, Mwakagile Davis S M, Jureen Roland, Msangi Viola, Tellevik Marit G, Holberg-Petersen Mona, Harthug Stig, Maselle Samwel Y, Langeland Nina
Department of Medicine, Haukeland University Hospital, Bergen, Norway.
BMC Infect Dis. 2007 May 22;7:43. doi: 10.1186/1471-2334-7-43.
Bloodstream infection is a common cause of hospitalization, morbidity and death in children. The impact of antimicrobial resistance and HIV infection on outcome is not firmly established.
We assessed the incidence of bloodstream infection and risk factors for fatal outcome in a prospective cohort study of 1828 consecutive admissions of children aged zero to seven years with signs of systemic infection. Blood was obtained for culture, malaria microscopy, HIV antibody test and, when necessary, HIV PCR. We recorded data on clinical features, underlying diseases, antimicrobial drug use and patients' outcome.
The incidence of laboratory-confirmed bloodstream infection was 13.9% (255/1828) of admissions, despite two thirds of the study population having received antimicrobial therapy prior to blood culture. The most frequent isolates were klebsiella, salmonellae, Escherichia coli, enterococci and Staphylococcus aureus. Furthermore, 21.6% had malaria and 16.8% HIV infection. One third (34.9%) of the children with laboratory-confirmed bloodstream infection died. The mortality rate from Gram-negative bloodstream infection (43.5%) was more than double that of malaria (20.2%) and Gram-positive bloodstream infection (16.7%). Significant risk factors for death by logistic regression modeling were inappropriate treatment due to antimicrobial resistance, HIV infection, other underlying infectious diseases, malnutrition and bloodstream infection caused by Enterobacteriaceae, other Gram-negatives and candida.
Bloodstream infection was less common than malaria, but caused more deaths. The frequent use of antimicrobials prior to blood culture may have hampered the detection of organisms susceptible to commonly used antimicrobials, including pneumococci, and thus the study probably underestimates the incidence of bloodstream infection. The finding that antimicrobial resistance, HIV-infection and malnutrition predict fatal outcome calls for renewed efforts to curb the further emergence of resistance, improve HIV care and nutrition for children.
血流感染是儿童住院、发病和死亡的常见原因。抗菌药物耐药性和艾滋病毒感染对结局的影响尚未完全明确。
在一项前瞻性队列研究中,我们评估了1828例年龄在0至7岁、有全身感染迹象的儿童连续入院时血流感染的发生率及死亡结局的危险因素。采集血液进行培养、疟疾显微镜检查、艾滋病毒抗体检测,必要时进行艾滋病毒聚合酶链反应检测。我们记录了临床特征、基础疾病、抗菌药物使用情况及患者结局的数据。
尽管三分之二的研究人群在血培养前已接受抗菌治疗,但实验室确诊的血流感染发生率仍为入院人数的13.9%(255/1828)。最常见的分离菌为克雷伯菌、沙门菌、大肠杆菌、肠球菌和金黄色葡萄球菌。此外,21.6%的儿童患有疟疾,16.8%感染艾滋病毒。实验室确诊血流感染的儿童中有三分之一(34.9%)死亡。革兰阴性菌血流感染的死亡率(43.5%)是疟疾(20.2%)和革兰阳性菌血流感染(16.7%)死亡率的两倍多。经逻辑回归模型分析,死亡的显著危险因素包括因抗菌药物耐药导致的治疗不当、艾滋病毒感染、其他基础感染性疾病、营养不良以及由肠杆菌科细菌、其他革兰阴性菌和念珠菌引起的血流感染。
血流感染比疟疾少见,但导致的死亡更多。血培养前频繁使用抗菌药物可能妨碍了对包括肺炎球菌在内的常用抗菌药物敏感菌的检测,因此该研究可能低估了血流感染的发生率。抗菌药物耐药性、艾滋病毒感染和营养不良可预测死亡结局这一发现,要求我们重新努力遏制耐药性的进一步出现,改善儿童的艾滋病毒治疗和营养状况。